{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:39:20Z","timestamp":1788471560175,"version":"build-2803163510"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007488","name":"Indian Institute of Technology Delhi","doi-asserted-by":"publisher","award":["MI02543G"],"award-info":[{"award-number":["MI02543G"]}],"id":[{"id":"10.13039\/501100007488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/17\/2020\/NCD-III"],"award-info":[{"award-number":["5\/13\/17\/2020\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["2019-0154\/CMB\/Adhoc\/BMS"],"award-info":[{"award-number":["2019-0154\/CMB\/Adhoc\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.compbiomed.2025.111142","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:13:20Z","timestamp":1759853600000},"page":"111142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PA","title":["CKS2 is overexpressed in high-grade and recurrent meningiomas and functions as an oncogene via the CKS2\/miR-26a\/miR-101 axis"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7651-4944","authenticated-orcid":false,"given":"Anuja","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4749-8967","authenticated-orcid":false,"given":"Ritanksha","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7111-1275","authenticated-orcid":false,"given":"Deepshikha","family":"Shahdeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4631-6371","authenticated-orcid":false,"given":"Jyotsna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-8194","authenticated-orcid":false,"given":"Vaishali","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0488-5048","authenticated-orcid":false,"given":"Ritu","family":"Kulshreshtha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.111142_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016\u20142020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib2","doi-asserted-by":"crossref","unstructured":"Epidemiology and etiology of meningioma | J. Neuro Oncol.,99(3):307\u2013314 (n.d.). https:\/\/link.springer.com\/article\/10.1007\/s11060-010-0386-3 (accessed July 16, 2024).","DOI":"10.1007\/s11060-010-0386-3"},{"key":"10.1016\/j.compbiomed.2025.111142_bib3","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00701-022-05301-y","article-title":"The WHO 2021 classification of central nervous system tumours: a practical update on what neurosurgeons need to know\u2014a minireview","volume":"164","author":"Torp","year":"2022","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.compbiomed.2025.111142_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1137849","article-title":"Intracranial meningiomas: an update of the 2021 world health organization classifications and review of management with a focus on radiation therapy","volume":"13","author":"Yarabarla","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11060-022-04148-8","article-title":"Emerging systemic treatment options in meningioma","volume":"161","author":"Mair","year":"2023","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib6","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.18632\/oncotarget.26941","article-title":"Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomas","volume":"10","author":"Loewenstern","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2025.111142_bib7","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","article-title":"Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation","volume":"22","author":"Vasudevan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.compbiomed.2025.111142_bib8","doi-asserted-by":"crossref","DOI":"10.3892\/ijo_00000457","article-title":"Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype","volume":"35","author":"F\u00e8vre-Montange","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib9","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/NEN.0b013e31826bf704","article-title":"Genetic alterations associated with progression and recurrence in meningiomas","volume":"71","author":"P\u00e8rez-Mag\u00e1n","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.20733","article-title":"Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression","volume":"114","author":"Wrobel","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.compbiomed.2025.111142_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1476-4598-6-64","article-title":"Molecular signatures define two main classes of meningiomas","volume":"6","author":"Carvalho","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.compbiomed.2025.111142_bib12","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2013.10.FOCUS13326","article-title":"Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas","volume":"35","author":"Chang","year":"2013","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.compbiomed.2025.111142_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3171\/2022.7.JNS22953","article-title":"Impact of a cell cycle and an extracellular matrix remodeling transcriptional signature on tumor progression and correlation with EZH2 expression in meningioma","volume":"138","author":"Pereira","year":"2023","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.compbiomed.2025.111142_bib14","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3171\/2022.7.JNS22585","article-title":"Gene expression analysis during progression of malignant meningioma compared to benign meningioma","volume":"138","author":"Maier","year":"2023","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.compbiomed.2025.111142_bib15","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","article-title":"Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma","volume":"65","author":"Lusis","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.111142_bib16","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1634\/theoncologist.2010-0249","article-title":"DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence","volume":"16","author":"Menghi","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.compbiomed.2025.111142_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067291","article-title":"Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma","volume":"8","author":"Serna","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2025.111142_bib18","doi-asserted-by":"crossref","first-page":"16087","DOI":"10.18632\/oncotarget.24498","article-title":"A gene expression signature predicts recurrence-free survival in meningioma","volume":"9","author":"Olar","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2025.111142_bib19","doi-asserted-by":"crossref","first-page":"21715","DOI":"10.1073\/pnas.1912858116","article-title":"Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors","volume":"116","author":"Patel","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.compbiomed.2025.111142_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ijc.23942","article-title":"Genome wide expression profiling identifies specific deregulated pathways in meningioma","volume":"124","author":"Keller","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.compbiomed.2025.111142_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052707","article-title":"Analysis of gene expression profiling in meningioma: deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2025.111142_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3892\/ol.2013.1363","article-title":"Gene expression analysis of aberrant signaling pathways in meningiomas","volume":"6","author":"Torres-Mart\u00edn","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.compbiomed.2025.111142_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","article-title":"Genomic landscape of meningiomas","volume":"20","author":"Lee","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/neuros\/nyaa355","article-title":"A prognostic gene-expression signature and risk score for meningioma recurrence after resection","volume":"88","author":"Chen","year":"2020","journal-title":"Neurosurgery"},{"key":"10.1016\/j.compbiomed.2025.111142_bib25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3892\/ijo.2014.2779","article-title":"Gene expression profile for predicting survival of patients with meningioma","volume":"46","author":"Chen","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib26","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/s41591-023-02642-8","article-title":"Meningioma risk stratification with a targeted gene-expression biomarker","volume":"29","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2025.111142_bib27","author":"Raleigh"},{"key":"10.1016\/j.compbiomed.2025.111142_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/neuonc\/noad212","article-title":"A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responses","volume":"26","author":"Raleigh","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib29","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1038\/s41467-020-18582-7","article-title":"Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma","volume":"11","author":"Magill","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2025.111142_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3182018f1c","article-title":"Identification of gene markers associated with aggressive meningioma by filtering across multiple sets of gene expression arrays","volume":"70","author":"Stuart","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.541928","article-title":"Gene expression signatures identify biologically homogenous subgroups of grade 2 meningiomas","volume":"10","author":"Zador","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74482-2","article-title":"Meta-gene markers predict meningioma recurrence with high accuracy","volume":"10","author":"Zador","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2025.111142_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08931-0","article-title":"Identification of key genes and pathways associated with resting mast cells in meningioma","volume":"21","author":"Xie","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.compbiomed.2025.111142_bib34","first-page":"430","article-title":"Bioinformatic analyses determine the importance of CXCL2 and CXCL8 in atypical meningioma development and reoccurrence","volume":"32","author":"Cao","year":"2022","journal-title":"Turk Neurosurg."},{"key":"10.1016\/j.compbiomed.2025.111142_bib35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12032-022-01869-8","article-title":"Identification of key genes of anti-programmed death ligand 1 for meningioma immunotherapy by bioinformatic analysis","volume":"40","author":"Zhang","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib36","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1016\/j.wneu.2023.05.090","article-title":"Identification of the key immune cells and genes for the diagnostics and therapeutics of meningioma","volume":"176","author":"Chen","year":"2023","journal-title":"World Neurosurg."},{"key":"10.1016\/j.compbiomed.2025.111142_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","article-title":"Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities","volume":"54","author":"Choudhury","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.compbiomed.2025.111142_bib38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/neuonc\/noac224","article-title":"Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features","volume":"25","author":"Choudhury","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib39","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00432-015-1930-5","article-title":"DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade","volume":"141","author":"Majchrzak-Celi\u0144ska","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The gene expression omnibus database","author":"Clough","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1750-3639.2008.00191.x","article-title":"Gene expression profiles of meningiomas are associated with tumor cytogenetics and patient outcome","volume":"19","author":"Tabernero","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib42","doi-asserted-by":"crossref","first-page":"14551","DOI":"10.18632\/oncotarget.7396","article-title":"Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade","volume":"7","author":"Schmidt","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiomed.2025.111142_bib43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/neuonc\/nov014","article-title":"Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs","volume":"17","author":"Ludwig","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib44","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111142_bib45","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111142_bib46","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.compbiomed.2025.111142_bib47","unstructured":"cytoHubba: identifying hub objects and sub-networks from complex interactome | BMC Systems Biology | Full Text, (n.d.). https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/1752-0509-8-S4-S11 (accessed June 25, 2024)."},{"key":"10.1016\/j.compbiomed.2025.111142_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2025.111142_bib49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"Zweig","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.compbiomed.2025.111142_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.compbiomed.2025.111142_bib51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.compbiomed.2025.111142_bib52","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance","volume":"56","author":"Glas","year":"2003","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib53","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.111142_bib54","unstructured":"TargetScanHuman 7.2, (n.d.). https:\/\/www.targetscan.org\/vert_72\/(accessed July 26, 2025)."},{"key":"10.1016\/j.compbiomed.2025.111142_bib55","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.21037\/tcr-19-2829","article-title":"Key genes involved in cell cycle arrest and DNA damage repair identified in anaplastic thyroid carcinoma using integrated bioinformatics analysis","volume":"9","author":"Zhang","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.111142_bib56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1186\/s12935-022-02747-z","article-title":"A review on the role of cyclin dependent kinases in cancers","volume":"22","author":"Ghafouri-Fard","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.compbiomed.2025.111142_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7926483","article-title":"miR-26a-5p suppresses Wnt\/\u03b2-Catenin signaling pathway by inhibiting DNMT3A-Mediated SFRP1 methylation and inhibits cancer stem cell-like properties of NSCLC","volume":"2022","author":"Yu","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.compbiomed.2025.111142_bib58","unstructured":"P. Zapolnik, B. Zapolnik, MicroRNA-26a-5p: multiple functions, multiple possibilities \u2013 a mini-review, (n.d.). https:\/\/doi.org\/10.26444\/jpccr\/128009.."},{"key":"10.1016\/j.compbiomed.2025.111142_bib59","unstructured":"How kinesin motor proteins drive mitotic spindle function: lessons from molecular assays - PMC, (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2844474\/(accessed July 17, 2024)."},{"key":"10.1016\/j.compbiomed.2025.111142_bib60","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1126\/science.279.5350.519","article-title":"Kinesin and dynein superfamily proteins and the mechanism of organelle transport","volume":"279","author":"Hirokawa","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2025.111142_bib61","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/cancers11040545","article-title":"Identification of KIF11 as a novel target in meningioma","volume":"11","author":"Jungwirth","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.compbiomed.2025.111142_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.02.016","article-title":"KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo","volume":"506","author":"Jungwirth","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.compbiomed.2025.111142_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103137","article-title":"Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis","volume":"72","author":"Ye","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib64","first-page":"469","article-title":"Upregulation of cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion","volume":"12","author":"Aljohani","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.compbiomed.2025.111142_bib65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12885-023-10755-z","article-title":"Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker","volume":"23","author":"Tang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.compbiomed.2025.111142_bib66","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3892\/ol.2016.4272","article-title":"Correlation of leptin receptor expression with BMI in differential grades of human meningiomas","volume":"11","author":"Rutkowski","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.compbiomed.2025.111142_bib67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40478-019-0793-4","article-title":"Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT","volume":"7","author":"Jungwirth","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.compbiomed.2025.111142_bib68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/CM9.0000000000001662","article-title":"Relationships between SLC26A7 expressions and extra-thyroid metastasis of papillary thyroid carcinoma","volume":"135","author":"Huang","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.compbiomed.2025.111142_bib69","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2184.2000.00191.x","article-title":"Cell cycle checkpoints and their inactivation in human cancer","volume":"33","author":"Molinari","year":"2000","journal-title":"Cell Prolif."},{"key":"10.1016\/j.compbiomed.2025.111142_bib70","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11060-018-2891-8","article-title":"Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design","volume":"139","author":"Everson","year":"2018","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib71","article-title":"Comprehensive analysis of the glutathione S-transferase Mu (GSTM) gene family in ovarian cancer identifies prognostic and expression significance","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib72","article-title":"Caspase-1 and gasdermin D afford the optimal targets with distinct switching strategies in NLRP1b inflammasome-induced cell death","author":"Li","year":"2022","journal-title":"Research 2022"},{"key":"10.1016\/j.compbiomed.2025.111142_bib73","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s13238-020-00810-x","article-title":"RIP1-dependent linear and nonlinear recruitments of caspase-8 and RIP3 respectively to necrosome specify distinct cell death outcomes","volume":"12","author":"Li","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.compbiomed.2025.111142_bib74","first-page":"3225","article-title":"CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer","volume":"23","author":"Xu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.compbiomed.2025.111142_bib75","first-page":"729","article-title":"Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma","volume":"26","author":"Wang","year":"2013","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.compbiomed.2025.111142_bib76","unstructured":"MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2 - PubMed, (n.d.). https:\/\/pubmed.ncbi.nlm.nih.gov\/27633373\/(accessed September 8, 2024)."},{"key":"10.1016\/j.compbiomed.2025.111142_bib77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/liv.12014","article-title":"Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma","volume":"33","author":"Shen","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.compbiomed.2025.111142_bib78","doi-asserted-by":"crossref","unstructured":"M. Hu, Z. Li, J. Qiu, R. Zhang, J. Feng, G. Hu, J. Ren, CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry, Bioengineered 12 (n.d.) 5996\u20136009. https:\/\/doi.org\/10.1080\/21655979.2021.1972197..","DOI":"10.1080\/21655979.2021.1972197"},{"key":"10.1016\/j.compbiomed.2025.111142_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3892\/mco.2015.501","article-title":"CKS2 in human cancers: clinical roles and current perspectives","volume":"3","author":"You","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib80","doi-asserted-by":"crossref","first-page":"36839","DOI":"10.1074\/jbc.274.52.36839","article-title":"The xenopus Suc 1\/Cks protein promotes the phosphorylation of G2\/M regulators","volume":"274","author":"Patra","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiomed.2025.111142_bib81","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1083\/jcb.200912084","article-title":"The APC\/C recruits cyclin B1\u2013Cdk1\u2013Cks in prometaphase before D box recognition to control mitotic exit","volume":"190","author":"van Zon","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib82","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1073\/pnas.1102434108","article-title":"Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins","volume":"109","author":"Liberal","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.compbiomed.2025.111142_bib83","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1128\/MCB.01833-07","article-title":"Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells","volume":"28","author":"Martinsson-Ahlz\u00e9n","year":"2008","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib84","first-page":"141","article-title":"Cell cycle: principles of control","volume":"80","author":"Crosby","year":"2007","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.compbiomed.2025.111142_bib85","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nbt.3001","article-title":"The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance","volume":"32","author":"Wang","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.compbiomed.2025.111142_bib86","article-title":"Large scale comparison of gene expression levels by microarrays and RNAseq using TCGA data","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2025.111142_bib87","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1186\/1471-2164-15-1008","article-title":"Transfer of clinically relevant gene expression signatures in breast cancer: from affymetrix microarray to illumina RNA-sequencing technology","volume":"15","author":"Fumagalli","year":"2014","journal-title":"BMC Genom."},{"key":"10.1016\/j.compbiomed.2025.111142_bib88","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2217\/bmm.15.97","article-title":"Comparative analysis of oncogenes identified by microarray and RNA-sequencing as biomarkers for clinical prognosis","volume":"9","author":"Liu","year":"2015","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.compbiomed.2025.111142_bib89","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12864-025-11548-3","article-title":"An updated comparison of microarray and RNA-seq for concentration response transcriptomic study: case studies with two cannabinoids, cannabichromene and cannabinol","volume":"26","author":"Gao","year":"2025","journal-title":"BMC Genom."},{"key":"10.1016\/j.compbiomed.2025.111142_bib90","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.cardfail.2014.06.233","article-title":"RNA sequencing, microarray hybridization, and quantitative PCR produce complementary, concordant results in longitudinal analysis of myocardial gene expression in dilated cardiomyopathy patients","volume":"20","author":"Kao","year":"2014","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.compbiomed.2025.111142_bib91","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1186\/1471-2164-13-629","article-title":"RNA-seq and microarray complement each other in transcriptome profiling","volume":"13","author":"Kogenaru","year":"2012","journal-title":"BMC Genom."},{"key":"10.1016\/j.compbiomed.2025.111142_bib92","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1186\/s12967-023-04620-7","article-title":"Meningioma animal models: a systematic review and meta-analysis","volume":"21","author":"Andersen","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.compbiomed.2025.111142_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-83456-7","article-title":"Orthotopic meningioma rat model exhibits morphological and immunohistochemical congruency and epigenetic concordance with benign primary patient-derived tumors","volume":"14","author":"Andersen","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525014957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525014957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:47:22Z","timestamp":1780548442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525014957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":93,"alternative-id":["S0010482525014957"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111142","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CKS2 is overexpressed in high-grade and recurrent meningiomas and functions as an oncogene via the CKS2\/miR-26a\/miR-101 axis","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.111142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111142"}}